A Phase 1, Open-label, Single-Dose Study to Investigate the Pharmacokinetics of DSP-6952 in Healthy Elderly and Young Males and Females
Latest Information Update: 17 Dec 2021
Price :
$35 *
At a glance
- Drugs Minesapride (Primary)
- Indications Constipation; Irritable bowel syndrome
- Focus Pharmacokinetics
- Sponsors Sumitomo Dainippon Pharma
- 17 Dec 2021 New trial record